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ABSTRACT
Removal of the poly(A) tail is the first step in the
degradation of many eukaryotic mRNAs. In meta-
zoans and yeast, the Ccr4/Caf1/Not complex has
the predominant deadenylase activity, while the
Pan2/Pan3 complex may trim poly(A) tails to the
correct size, or initiate deadenylation. In trypano-
somes, turnover of several constitutively-expressed
or long-lived mRNAs is not affected by depletion
of the 5’–3’ exoribonuclease XRNA, but is almost
completely inhibited by depletion of the deadeny-
lase CAF1. In contrast, two highly unstable
mRNAs, encoding EP procyclin and a phosphogly-
cerate kinase, PGKB, accumulate when XRNA levels
are reduced. We here show that degradation of EP
mRNA was partially inhibited after CAF1 depletion.
RNAi-targeting trypanosome PAN2 had a mild effect
on global deadenylation, and on degradation of
a few mRNAs including EP. By amplifying and
sequencing degradation intermediates, we demon-
strated that a reduction in XRNA had no effect on
degradation of a stable mRNA encoding a ribosomal
protein, but caused accumulation of EP mRNA frag-
ments that had lost substantial portions of the 5’
and 3’ ends. The results support a model in which
trypanosome mRNAs can be degraded by at least
two different, partially independent, cytoplasmic
degradation pathways attacking both ends of the
mRNA.
INTRODUCTION
Messenger RNA degradation is an important component
of the control of gene expression in eukaryotes. Messenger
RNAs are generally protected from degradation by the
interaction of poly(A)-binding protein (PABP) with both
the poly(A) tail at the 30-end, and the cap-binding complex
at the 50-end (1). In the simplest model, mRNA degrada-
tion is initiated by digestion of the poly(A) tail; once the
tail has been shortened below a certain threshold length,
poly(A)-binding protein drops oﬀ, the interaction with the
50-end is disrupted and the RNA ends become available
for digestion (2,3). Three major deadenylases are known:
PARN, Pan2/Pan3 and the Ccr4/Caf1/Not complex.
The poly(A) ribonuclease PARN has specialized func-
tions, such as deadenylation of stored mRNAs during the
maturation of oocytes (4,5) and regulation of embryogen-
esis in plants (6). It is stimulated by PABP (7) and by
binding to the 50 cap (5).
The Ccr4/Caf1/Not complex has the major deadenyla-
tion activity in animal cells and yeast. (8,9). In some
organisms, including yeast and mammals, it contains
two catalytic subunits, Ccr4 and Caf1. Ccr4 is bound to
Caf1, which in turn interacts with the scaﬀold protein
Not1. Several other subunits, with stimulatory or other
functions, are also associated with Not1 (10–12).
Although Ccr4 is the most active deadenylase in the
Saccharomyces cerevisiae Ccr4/Caf1/Not complex (13),
Caf1 is more important in animal cells (8,14–16).
Indeed, whereas Caf1 is conserved throughout eukaryotic
evolution, Ccr4 is absent in many species. In some
mammalian in vitro extracts, degradation of an mRNA
substrate is stimulated by addition of poly(A) oligori-
bonucleotides, suggesting that the major deadenylation
activity is inhibited by PABP (3,17). This would corre-
late with the known inhibition of Ccr4/Caf1/Not
by PABP (18).
Pan2 is the catalytic subunit of the Pan2/Pan3 deade-
nylase and is a member of the DEDDh subfamily of exo-
nuclease III enzymes. In contrast with Caf1, the activity
of the complex is stimulated by PABP in vitro (19,20).
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acts with Pan2, while the N-terminus interacts with PABP
(20,21). Pan3 also has a central kinase domain, the role of
which is unknown. Pan2/3 is found in the yeast nucleus
and cytoplasm. In the nucleus, it trims the poly(A) tails of
newly synthesized mRNAs to speciﬁc lengths (22) while
the cytoplasmic fraction plays a role in mature mRNA
deadenylation (12). Neither Pan2 nor Pan3 is essential
for yeast growth (23,24) but their absence results in
longer bulk poly(A) tails in vivo.I nDrosophila Schneider
cells Pan2 contributes to the deadenylation of the hsp70
mRNA during recovery from heat shock (25). There
is evidence that in mammalian cells, the Pan2/Pan3
deadenylase initiates cytoplasmic deadenylation (26).
After deadenylation, mRNAs can be degraded either
unidirectionally from either end, or from both ends; the
nature of the mRNA and the species determine which
pathway predominates. Results from work in S. cerevisiae
showed that the major pathway for degradation of
some unstable deadenylated mRNAs is decapping, by a
complex containing the MutT hydrolase Dcp2, then
degradation by the 50!30 exonuclease Xrn1 (27–29).
Alternatively, or in addition, deadenylated transcripts
can be degraded by 30–50 exonucleases associated with
the exosome (30,31); in this case the residual cap structure
is degraded by the scavenger decapping enzyme DcpS (32).
Computer modelling of mRNA degradation in yeast indi-
cated that modulation of deadenylation has a stronger
eﬀect on mRNA half-life and levels than changes in dec-
apping or the 30–50 and 50–30 decay pathways (33).
Mammalian mRNAs that are destabilized by AU-rich
elements (ARE) in the 30-untranslated region (UTR) are
subject to accelerated deadenylation (34–36) followed by
digestion by 50–30 and 30–50 pathways (37,38). 50 degrada-
tion is also important in Drosophila cells (25). In contrast,
the stability of the alpha globin mRNA depends on bind-
ing of a complex that inhibits 30–50 decay (39). The 30
pathway has also been shown to be important during
degradation of mammalian mRNAs with premature
termination codons (nonsense-mediated mRNA decay,
or NMD) (40–42). In mammalian cells, the decapping
enzyme, Xrn1, Dhh1, Pan2 and Caf1 co-localize in cyto-
plasmic processing bodies (P-bodies) (15) which are
thought to be a site of mRNA decay.
Despite the importance of deadenylation, other dead-
enylation-independent mRNA degradation pathways
clearly exist. First, degradation may be initiated by an
endonuclease: examples include mammalian mRNAs sub-
ject to iron regulation (43), the alpha globin mRNA in
mammalian erythroid cells (44) and the albumin RNA
in Xenopus hepatocytes (45). In Drosophila and mamma-
lian cells some mRNAs with premature termination
codons (PTCs) are also attacked by an endonuclease
(46–48). In yeast, RNAs with PTCs (49) and the
mRNAs encoding the ribosomal protein Rps28b (50)
and the decapping enhancer Edc1 (51) are subject to dead-
enylation-independent decapping. In contrast, degrada-
tion of mRNAs lacking a stop codon depends primarily
on the exosome (52). Finally, degradation of mammalian
histone mRNAs, which are not polyadenylated, is
initiated by addition of poly(U) (53).
Trypanosomes are unicellular parasites which branched
from the Opisthokont (fungi/animal) line very early in
eukaryotic evolution (54). In trypanosomes, transcription
by RNA polymerase II is polycistronic (55), individual
mRNAs being generated by processing (trans splicing
and polyadenylation) (56,57). Control of polymerase II
initiation—even for the polycistronic units—has not
been documented. Nevertheless, gene expression is regu-
lated in order to allow trypanosomes to survive and grow
in the mammalian host (the ‘bloodstream form’) and
in the digestive tract of the Tsetse ﬂy (the ‘procyclic
form’) (58). To regulate gene expression, trypanosomes
are therefore heavily dependent on mRNA degradation.
The stability of trypanosome mRNAs is—as in other
eukaryotes—determined mainly by sequences in the
30-UTR (59). We have previously shown that degradation
of relatively stable, constitutively expressed mRNAs
depends on CAF1 activity (14). (Trypanosomes lack
CCR4.) Trypanosome extracts possess decapping activ-
ities (60), but the proteins involved have not been
identiﬁed. Of four XRN homologues, only XRNA has
so far been shown to play a role in mRNA decay
(61). Trypanosome XRNA and DHH1 are found in
P-bodies (62).
Our previous work on degradation of highly unstable,
developmentally regulated mRNAs has focussed mainly
on two mRNAs that are highly expressed in the procyclic
form trypanosomes, EP and PGKB. The EP mRNAs
encode the major surface proteins of procyclic cells, the
EP procyclins. Pairs of procyclin genes are arranged in a
tandem repeat which is transcribed by RNA polymerase I
(63). EP transcription is approximately 10-fold less eﬃ-
cient in bloodstream forms than in procyclic forms, most
likely a consequence of epigenetic control (64). The EP
mRNAs have a half-life of about 5min in bloodstream-
form trypanosomes, and over an hour in procyclic forms
(65). Regulation of procyclin protein expression is com-
pleted by blocks to translation and protein processing
(66). PGKB encodes a cytosolic phosphoglycerate kinase
that is speciﬁc to procyclic forms; it is co-transcribed with
the PGKC mRNA, which encodes a phosphoglycerate
kinase that is abundant in bloodstream forms (56). The
results of mathematical modelling indicate that mRNA
stability is the major determinant of PGKB and PGKC
expression (67).
Chloramphenicol acetyltransferase (CAT) reporter
mRNAs with 30-UTRs of either EP procyclin mRNA
(CAT-EP)o rPGKB mRNA (CAT-PGKB) are very unsta-
ble in bloodstream forms, with half-lives of around 5min
(68–70). The CAT-EP reporter thus has the same half-life
as endogenous EP mRNAs. The half-life of PGKB
mRNA has not been measured accurately because of
its low abundance (less than one molecule per cell), but
available data suggests a value of around 5min (67).
Mutational analyses on both reporters identiﬁed a
single-stranded poly(U) tract in the 30-UTR that was
required for mRNA instability (69–73). Analysis of the
kinetics of CAT-EP mRNA degradation indicated
that degradation occurs without accumulation of deade-
nylated intermediates, and that the RNA is destroyed by
both 50–30 and 30–50 exoribonuclease activities (68).
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the 50–30 exonuclease XRNA (61) delays degradation
of the CAT-EP and CAT-PGKB mRNAs. The results of
XRNA depletion are more dramatic, with general disrup-
tion of PGKB and PGKC regulation: steady-state PGKB
mRNA increases in bloodstream forms, while PGKC
mRNA appears in procyclics (61). Analysis of CAT-EP
degradation intermediates also suggested action of
both deadenylation-dependent and -independent mRNA
degradation pathways. In this article we investigate the
roles of trypanosome CAF1 and PAN2 in rapid mRNA
degradation.
MATERIALS AND METHODS
Sequence alignments
To ﬁnd PAN2 and PAN3 genes, we searched various
genomes using BLASTp, with the S. cerevisiae PAN2 or
PAN3 protein sequences as the query, and then used the
top match (or matches) as queries for the S. cerevisiae
genome. Protein sequences that yielded S. cerevisiae
PAN2 or PAN3 as the best match were categorized as
potential homologues. Sequence alignments were done
using ClustalW, with DNAStar software. Functional
motifs were found using Prosite and NCBI searches.
Trypanosome culture, RNAi and plasmids
Bloodstream form Trypanosoma brucei stably expressing
the tetracycline repressor (pHD 1313) and T7 RNA poly-
merase (pHD 514) were grown, transfected and clonally
selected as described (75). The plasmids used in this study
are described in Table S1. For CAF1 and PAN3 RNAi
the vector p2T7
TA blue (75) was used to make dsRNA from
opposing tetracycline-inducible T7 promoters. In the
PAN2 and MEX67 RNAi constructs, an inducible RNA
polymerase I promoter drove expression of stem-loops
(76). The plasmids were linearized with Not I and trans-
fected into bloodstream-form trypanosomes expressing
the tet repressor and T7 RNA polymerase (77).
Transfectants were selected with 10mg/ml hygromycin.
The RNAi was induced by adding 1mg/ml tetracycline
to the medium. Samples were taken after 18.5h of CAF1
RNAi induction or after 2–3 days after PAN2 RNAi
induction.
In situ V5 tagging was done using the V5 plasmid
described in (78), while over-expression of open reading
frames with two myc tags was done as in (79).
RNA preparation and blotting
To analyse mRNA decay the cells were treated with
Sinefungin (ﬁnal concentration 2mg/ml) for 5min then
Actinomycin D was added (ﬁnal concentration 10mg/ml)
(80). Total RNA was isolated using peqGold Trifast
(peqLab, Germany). To remove poly(A) tails, 170 pmol
oligo d(T)20 was incubated with 10–12mg total RNA at
428C for 10min, 5U RNase H (New England Biolabs)
and RNase H buﬀer were added and the mixture incu-
bated for 40min at 378C.
To select polyadenylated RNA, oligo d(T) cellulose (GE
Healthcare) was treated with 0.1M NaOH and washed
in RNA-binding buﬀer (20mM HEPES pH 7.4, 5mM
EDTA, 0.4% SDS, 500mM NaCl). A total of 20mg
RNA was dissolved in RNA denaturation buﬀer (20mM
HEPES pH 7.4, 10mM EDTA, 1% SDS). The mixture
was heated at 658C for 10min then put on ice. A 1.5 
volume of RNA dilution buﬀer (20mM HEPES pH 7.4,
800mM NaCl) was added. The RNA was transferred to a
tube containing 10mg resuspended oligo d(T) cellulose
and incubated for 10min at room temperature. After
centrifugation the supernatant contained the poly(A)–
fraction. The oligo d(T) cellulose was washed three times
with washing buﬀer (20mM HEPES, pH 7.4, 5mM
EDTA, 0.5% SDS). Poly(A)+ RNA was eluted with
water.
RNA was analysed by formaldehyde gel electrophor-
esis, blotting onto Nytran membranes (GE Healthcare)
and hybridization with radioactive DNA (Prime-IT
RmT Random Primer Labelling Kit, Stratagene) or anti-
sense RNA (MAXIscriptT7/T3, Ambion) probes. Signals
were measured using a phosphorimager and normalized
relative to the signal from a 7SL (signal recognition par-
ticle) probe. Northerns were stripped by brief boiling in
0.1% SDS; the eﬃcacy of stripping assessed by phosphor-
imager, and any residual signals left to decay as necessary
before re-use.
RNA half-lives were measured by plotting relative
signal intensities using Kaleidograph (Synergy software),
including only the segments of the time course that gave
exponential decay curves (ﬁtted with a linear correlation
coeﬃcient generally exceeding 0.9). To mathematically
describe the half-life of the EP transcript, we used
Microsoft Excel to build models, assuming the presence
of one or two exponential decay components. Since
XRNA depletion results in simple exponential kinetics
(half-life about 12min) we varied one half-life around
this value. The other half-life was varied from 1.5min
upwards; the proportions of mRNA aﬀected by each
pathway were also varied. The root mean square deviation
of the model from the data was calculated and the model
with minimum deviation adopted.
Poly(A) tail lengths were analysed as described pre-
viously (14). For pooled statistical analysis of time
points 5min, 15min and 30min, a Wilcoxon signed rank
test was used (81).
Analysis of circular RNAs
RNA samples (60mg, 400ml) were treated with 40 units
of DNase I (Invitrogen) with 240 units of RNaseOUT
(Invitrogen) for 30mins at room temperature. This
and all following reactions were terminated by phenol-
chloroform extraction and ethanol precipitation. To
remove the terminal cap,  10mg of DNase-treated RNA
was incubated with 2.5 units of Tobacco Acid
Pyrophosphatase (TAP; Epicentre Biotechnologies) and
40 units of RNaseOUT (Invitrogen) in a 20ml reaction
for 1h at 378C. To remove the cap with the modiﬁed
50 nt, 10mg of DNase-treated RNA was incubated with
100pmol of an oligonucleotide complementary to the
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T3 0)a t3 7 8Ci n3 3 ml of water. We than added 5ml( 1  
RNase H buﬀer) of RNase H buﬀer, 1ml (5U) of RNase
H and incubated for 1h at 378C. The RNA was extracted
with phenol/chloroform and ethanol precipitated.
Circularization of 10mg RNA was done in a reaction
volume of 400ml, using 40 units of T4 RNA ligase
(New England Biolabs) and 80 units of RNaseOUT
(Invitrogen), for 16h at 168C. For reverse transcription
 2mg of RNA were incubated with 50 pmol of gene-
speciﬁc reverse primer, 200 units SuperScript III RT
(Invitrogen) and 40 units RNaseOUT (Invitrogen) in a
20ml reaction. PCR ampliﬁcation was performed in a
30ml reaction [1ml of cDNA (5%), 10 pmol each of for-
ward and reverse primers, 2.5 units Taq DNA polymerase
(New England Biolabs)] (30s at 958C, 30s at 528C and 45s
at 728C). For the RPL37A mRNA, we used 38 cycles; for
EP, each PCR was for 30 cycles. PCR products were pur-
iﬁed and cloned into pGEMT-easy vector and randomly
selected clones sequenced. Details of the oligonucleotides
are in the Supplementary Data.
In situ hybridization
In situ hybridization followed approximately the protocols
published previously (62,82). Gene-frames (Thermo scien-
tiﬁc) were applied to glass slides, which were then coated
with poly-L-Lysine. For each slide chamber, 10
6 to 10
7
cells were pelleted, washed with PBS, and ﬁxed with
500ml of freshly prepared 4% (w/v) paraformaldehyde
for 18min. Fixed cells were pelleted, washed three times
in PBS, resuspended 200ml PBS then allowed to settle on
the slides overnight at 48C. Cells were permeabilized with
0.2% (v/v) TritonX-100 in PBS (30min), and washed three
times with PBS. Total 50ml hybridization buﬀer was
added per chamber: 10  Denhardt’s solution, 4  SSC,
1mM EDTA, 35% deionized formamide, 0.5mg/ml
tRNA, 2mU/ml RNase OUT. After 30min 60ng of
50Cy3-oligo d(T)30 was mixed with 10ml of hybridization
buﬀer and added to the hybridization mix. The chamber
was covered with a coverslip, slides were heated to 658C
for 3min., then incubated overnight at room temperature
in a humid box. Coverslips and gene frames were removed
and the slides were washed twice with 2  SSC (15min),
twice with 1  SSC (15min) and twice with PBS (5min).
Cells were stained with DAPI solution (100ng/ml,
15min), washed twice with PBS (5min) and allowed to
dry for 1h. Mounted preparations (Vectashield, Vector
laboratories, H-1000) were viewed within 24h.
Immunofluorescence
Totally 10
6 cells were ﬁxed in 4% paraformaldehyde/PBS
(w/v) for 20min. The cells were allowed to settle on a
poly-lysine coated glass slide (25min), permeabilized
with 0.2% (v/v) Triton X-100/PBS (room temperature,
20min). Slides were blocked with 0.5% (w/v) gelatine
(20min), incubated with a 1:100 dilution of mouse a-V5
(Invitrogen) for 1h, then a 1:500 dilution of the second-
ary antibody Alexa Fluor 488 goat a-mouse IgG
(Molecular probes) for 40min before repeated washing.
The kinetoplast and the nuclear DNA were stained with
100ng/ml DAPI/PBS for 10min.
Cell fractionation
The fractionation method was taken from (83). A total
of 2 10
8cells were washed in PBS and resuspended in
buﬀer A [150mM sucrose, 20mM KCl, 3mM MgCl2,
20mM HEPES–KOH (pH 7.9), 1mM DTT, complete
EDTA-free protease inhibitor (Roche)]. Igepal CA-630
was added to a ﬁnal concentration of 0.2%. The cells
were passed three times through a 27g needle. After a
centrifugation (13000rpm, minifuge, 10min) the super-
natant (cytosolic fraction) was kept and puriﬁed by an
additional centrifugation step, while the nuclear pellet
was resuspended in buﬀer A and passed 15 times through
a 27g needle. The nuclear fraction was pelleted again
(13000rpm, 10min) and washed once more before use.
RESULTS
The trypanosome genome encodes potential homologues
of PAN2 and PAN3
The trypanosome genome sequence encodes a single
potential PAN2: the locus, Tb927.6.1670, is designated
as a pseudogene in the 927 strain and is absent from the
(incomplete) genome sequence of the 427 strain, but the
gene is intact in other Kinetoplastid genomes (Figure S1).
Trypanosoma gambiense and T. brucei PAN2 genes are
identical in all but 19 (out of 3256) nt, but a T at position
2697 in the T. gambiense sequence is missing in the corre-
sponding T. brucei 927 sequence. To analyse the protein
sequence we therefore restored this residue; sequencing of
DNA from the 427 strain indeed revealed an intact open
reading frame (M. Carrington and L. Ellis, University of
Cambridge, personal communication).
Trypanosome PAN2, like the human and yeast pro-
teins, has a C-terminal exonuclease III domain of the
DEDDh RNase family (84), and this is the most conserved
part of the protein: it is 38% identical to the equivalent
portion of human PAN2. We compared the sequence with
that of other, diverse eukaryotes (Figure 1; Figure S1
shows the complete alignment). The PAN2 of Monosiga
brevicollis, the nearest unicellular relative to animals,
retains all three domains, as do the PAN2s of
Chlamydomonas and Dictyostelium discoideum. The
Chlamydomonas sequence has mutations in putative
active site and catalytic residues (20,84); for example,
Asp 1083 was shown to be essential for activity of
human PAN2 (20), but is missing in Chlamydomonas
PAN2. Aureococcus anophageﬀerens (a chromalveolate
alga), Naegleria (an amoeba), Micromonas pusilla (an
alga related to green plants) and Thalassiosira pseudonana
(a marine diatom) have truncated versions containing only
the exonuclease domain (Figures 1 and S1), but in all of
these apart from Thalassiosira, N-terminal active site resi-
dues are missing. We could not ﬁnd PAN2 in Arabidopsis,
Plasmodium, Entamoeba, Trichomonas,o rGiardia: in these
organisms the best match to PAN2 is another 30–50 exo-
ribonuclease of S. cerevisiae, Rnh70, which is involved in
maturation of 5S rRNA and tRNAs.
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missing from the trypanosome homologue. The central
peptidase-C19 like domain—similar to ubiquitin hydro-
lases—was 27% identical to the human PAN2 peptidase
domain and was recognized using default settings of the
NCBI domain recognition algorithm, but the score was
low (E – 5 10
 6) and the domain was not recognized
by Prosite. Moreover, in the putative TbPAN2 peptidase
domain, two of the three conserved active site residues (85)
are mutated (C!K, H!D). Thus T. brucei PAN2 is unli-
kely to have ubiquitin hydrolase activity.
A search of the trypanosome database for PAN3
yielded Tb11.01.5540. For the potential PAN3 sequences
found in a multi-organism search, sequence identities
varied between 20% and 30% (Figures 1 and S2). A cen-
tral kinase-like domain (SSF56112) was recognized in
some proteins but not others; the role of this domain is
unknown. The PABP-binding regions of yeast and human
PAN3 are at diﬀerent positions in the proteins, and are
not suﬃciently similar to enable us to determine whether
such a region is conserved in the trypanosome protein.
Interestingly, three organisms with truncated versions
of PAN2 had a candidate PAN3; but we could not
ﬁnd it in Thalassiosira, Monosiga, Chlamydomonas or
Dictyostelium, or in the organisms that lacked PAN2.
Although some searches may have failed because the gen-
omes were not 100% complete, and alternative algorithms
might yield additional PAN2 and PAN3 sequences, the
results so far indicate that both PAN2 and PAN3 have
been lost several times in eukaryotic evolution.
Trypanosome PAN2 is in the cytoplasm and is required
for normal growth
To ﬁnd the location of PAN2, we integrated a sequence
encoding a V5 epitope tag immediately upstream of the
gene, to create an N-terminal fusion. The resulting
V5-tagged protein was mostly in the cytoplasm by both
immunoﬂuorescence (Figure 2A) and cell fractionation
(Figure 2B). We inducibly expressed PAN3 with a
C-terminal myc tag; this was also in the cytoplasm (data
not shown). Because the signals were weak in comparison
with that from DHH1, we were unable to check whether
PAN2 or PAN3 were in P-bodies. Preliminary results
using co-immunoprecipitation suggested that a small
proportion of the PAN3-myc was associated with
V5-PAN2 (data not shown). Unfortunately, expression
of PAN3-myc was rapidly lost during cultivation of the
cell line, precluding further analysis. Attempts to tag the
PAN2 gene in situ with a TAP tag failed, and we have so
far been unable to express PAN2 in E. coli.
We made several diﬀerent trypanosome lines with
tetracycline-inducible RNA interference targeting PAN2
or PAN3. Induction of PAN3 RNAi did not aﬀect
growth (data not shown). In contrast, cells with PAN2
RNAi showed variable levels of growth inhibition.
Figure 2C shows cultures that ceased growth completely
after PAN2 depletion, whereas the line illustrated in
Figure 2D were less aﬀected; another line (data not
shown) had a division time of 6.7h without tetracycline
and 8.2h after RNAi induction. All lines rapidly lost
RNAi upon either storage or propagation, and some
grew slowly in the absence of tetracycline, suggesting leak-
age of the RNAi. These problems, which are common in
trypanosome clones with detrimental inducible RNAi,
prevented us from conducting extensive series of experi-
ments with individual inducible cell lines.
From these experiments, we concluded that PAN2 is
in the trypanosome cytoplasm, is probably required for
optimal growth, and might be essential. It is not clear
whether, in trypanosomes, PAN2 is stably associated
with PAN3, and we have no evidence that PAN3 is
required for PAN2 function.
Depletion of PAN2 decreases deadenylation
To ﬁnd out whether PAN2 is important for mRNA dead-
enylation in trypanosomes, we measured bulk poly(A) tail
lengths in cells with or without RNAi, and after inhibition
of transcription. Cells with PAN2 RNAi reproducibly had
more poly(A), as judged by the signals on the autoradio-
grams (Figure 3A). Although equal amounts of starting
RNA were used for each reaction, this eﬀect cannot
be quantitated accurately because the design of the assay
precludes inclusion of a loading control. Instead, to mea-
sure the eﬀect of RNAi, we analysed the distributions
of poly(A) tail lengths within each sample (Figure 3B).
At steady state (time = 0), there was no signiﬁcant diﬀer-
ence in poly(A) tail lengths between the normal and
PAN2-depleted cells, but after transcription inhibition,
deadenylation was delayed. Quantitation of the relative
intensities of the signals for short (0–15), intermediate
(51–100) and long (101–200) poly (A) tails revealed that
after 5, 15 and 30min of transcription inhibition, the sam-
ples from PAN2-depleted cells had longer poly(A) tails
than samples from the normal cells (Figure 3B). The
eﬀect was weaker than that seen upon depletion of
CAF1 (14). This could indicate that PAN2 has a minor
role in deadenylation of all mRNAs, or that it attacks only
a subset of mRNAs. It is also possible that the weakness
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Figure 1. Cartoon maps of PAN2 and PAN3 from various species, as
indicated on the left. Domains recognized by Prosite are also shown.
Sc: Saccharomyces cerevisiae; Hs: Homo sapiens; Tb: T. brucei; Clamy:
Chlamydomonas reinhardtii; Thp: Thalassiosira pseudonana; Neig:
Naegleria fowleri; Aure: Aureococcus anophageﬀerens; Micp:
Micromonas pusilla. EXOc is the exoribonuclease domain; ‘Kin’ is the
putative kinase domain. The downward arrows indicate the approxi-
mate positions of residues thought to be required for catalytic activity
according to an NCBI domain search and speciﬁcations for the
cd06143 sequence cluster [e.g. (114,115)]. Complete sequence alignments
are provided as Figures S1 (PAN2) and S2 (PAN3).
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We previously showed that CAF1 RNAi strongly inhib-
its degradation of constitutively-expressed trypanosome
mRNAs, such as those encoding glycosomal PGKC,
histone H4 (HISH4), tubulin (TUB) or actin (ACT) [(14)
and see also Figure 4A]. PAN2 depletion, like CAF1
depletion, did not cause an increase in steady-state levels
of these mRNAs (Figure 3D and E, and data not shown).
PAN2 depletion had no signiﬁcant eﬀect on HISH4
(Figures 3D) or TUB (Figure S3) mRNA decay. In
Figure S3 we show the mRNA degradation curves nor-
malized to wild-type, so that any eﬀects of RNAi on in
steady-state mRNA levels are apparent. ACT RNA was
slightly more stable in PAN2-depleted cells (Figure 3C
and E). This eﬀect was clearest 30min after RNA synthe-
sis inhibition: at this time point, in ﬁve out of ﬁve experi-
ments, there was more mRNA left in the RNAi-induced
cells than in the controls. At 60min, ACT mRNA was
undetectable in the control samples but detectable in the
RNAi samples. We concluded that PAN2 depletion
aﬀected decay of the ACT mRNA.
Deadenylation plays a role in degradation of the
unstable EP mRNA
We previously showed that RNAi targeting the 50–30
exonuclease XRNA in bloodstream forms caused accu-
mulation of the unstable EP procyclin and PGKB
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Figure 2. PAN2 is mainly in the cytoplasm and RNAi inhibits trypanosome growth. (A) In bloodstream-form or procyclic-form trypanosomes, one
PAN2 allele was tagged in situ at the N terminus with a sequence encoding a V5 tag. The tag was detected by immunoﬂuorescence. DAPI staining
shows the positions of the nucleus (large spot) and kinetoplast DNA (small dot). A phase-contrast image of the trypanosome is on the right.
(B) Detergent lysates (T) from the V5-tagged cells were separated into nuclear (N) and cytoplasmic (C) fractions and proteins detected by western
blotting. XRND: nuclear exoribonuclease (61); TR: trypanothione reductase. (C) PAN2 RNAi inhibits trypanosome growth. Results for two
bloodstream-form cell lines are shown; each expresses the tet repressor and T7 polymerase (1313-514) and has an integrated copy of the PAN2
RNAi plasmid. Cells were grown with (open circles, dashed lines) or without (closed circles) tetracycline added at day 0, and were diluted as required.
Cumulative growth curves are shown, with doubling times calculated from exponential curves (Kaleidograph). The results are for two lines expressing
the CAT-GC-EP reporter. The panels beneath are northern blots probed for PAN2, with 7SL as a control. In the right hand panel, PAN2 mRNA
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panel below is a western blot that was probed with antibody to the V5 tag and to aldolase.
5516 Nucleic Acids Research, 2009, Vol. 37,No. 16mRNAs. In addition, a role for deadenylation was
indicated by the existence of deadenylated EP and
CAT-EP mRNA (61,74). We therefore analysed the
eﬀects of both CAF1 and PAN2 depletion on EP
mRNA turnover. HISH4 mRNA was included as a
control for deadenylation inhibition in the CAF1-
depleted cells.
After inhibition of transcription, in cells without RNAi
induction, EP procyclin transcripts showed an initial rapid
decrease, followed by a slower phase (Figure 4A). The
kinetics could be explained by the existence of two expo-
nential decay components: about half of the RNA had a
half-life of around 2min and the rest, a half-life of 14min.
After CAF1 RNAi, the abundance of EP transcripts
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Figure 3. PAN2 depletion inhibits deadenylation. (A) Trypanosome RNAs were 30 labelled with [
32P]-pCp then digested with RNase T1 and RNase
A to leave the poly(A) tails. The resulting RNA was separated on a denaturing polyacrylamide gel and the [
32P] was detected using a phosphor-
imager. The downward arrows indicate depletion of PAN2 by RNAi. The ‘+’ sign indicates that PAN2 is present (RNAi line in the absence of
tetracycline). (B) Quantitation of (A). The poly(A) tails were divided into three size classes, as indicated on the right, and the signal from each class
measured. The proportion of each class, relative to the total signal on the relevant lane, was then measured. This quantitation minimizes the eﬀect of
PAN2 depletion since it does not show the diﬀerences in total signal intensity between lanes. Results are the arithmetic mean of three independent
measurements with standard deviations. Individual sets of three measurements that were signiﬁcantly diﬀerent in a Student’s t-test (P<0.05, 30-min
time points) are shown with asterisks. The results for 5min, 15min and 30min were also pooled and compared using a Wilcoxon ranking test (see
numbers above the lanes). Tails of 0–50nt were less abundant in the PAN2 RNAi samples than in the control in 15/15 cases, giving a P-value of
<0.01. The longer tails of 51–100nt and 101–200nt were more abundant in the PAN2 RNAi samples (P-values of 0.02 and <0.01, respectively). (C)
Northern blots showing amounts of various mRNAs after inhibition of mRNA synthesis. Sinefungin was added at time –5min, and Actinomycin D
was added at time=0. ACT: actin; HISH4: Histone H4; 7SL: RNA of the signal recognition particle. Lanes labelled A- contain RNA that was
incubated with oligo d(T) and RNase H before loading. Signals were detected and measured using a phosphorimager, using the 7SL RNA as a
loading control. (D) Quantitation of results for the HISH4 mRNA. Means and standard deviations for four independent measurements are shown,
with ﬁtted exponential degradation curves (Kaleidograph) and corresponding half-lives. For quantitation of all measurements relative to wild-type
values see Figure S3. (E) Quantitation of results for the ACT mRNA. Means and standard deviations for ﬁve independent measurements are shown.
The result of a Student’s t-test for the 30-min time point is indicated on the graph. The diﬀerences at 30min were also signiﬁcant (P<0.02) in the
Wilcoxon ranking test.
Nucleic Acids Research, 2009,Vol.37, No. 16 5517increased 1.2- to 3.1-fold, and their degradation was inhib-
ited (Figures 4A and S3B). After CAF1 depletion, the deg-
radation kinetics were best explained by a model in which
half of the RNA was degraded with a half-life of 12min
and the remainder had a half-life of over 8h: even after
90min, 45% of the EP mRNA persisted. From these
kinetics, it appeared that half of the EP mRNA is
degraded by a pathway that depends on CAF1.
In the PAN2 RNAi cell line, EP mRNA had a half-
life of about 7min in the absence of RNAi induction,
suggesting some inhibition of degradation because of
RNAi ‘leakage’. With PAN2 RNAi, degradation was fur-
ther inhibited and 10% appeared to be stable (Figures 4B
and S3A). These results suggest that PAN2 is required for
optimal EP mRNA degradation. We cannot make any
judgements concerning the relative importance of the
two deadenylases in EP mRNA degradation since we do
not know the extents of PAN2 and CAF1 depletion and—
even if we did—we do not know the threshold below
which depletion might have an eﬀect. Digestion with
oligo d(T) and RNaseH increased the mobility of EP
mRNA, suggesting the presence of a poly(A) tail of at
least 50nt (Figure 4A and B).
We had previously shown that XRNA RNAi inhibited
the degradation of a CAT-EP reporter mRNA. We now
examined the eﬀect of XRNA RNAi on EP mRNA deg-
radation (Figure 4C). The graph quantitates the  900-nt
mature EP mRNA. Degradation in cells without the
RNAi construct was biphasic as expected. Uninduced
XRNA RNAi cells showed a slight retardation of the
degradation, relative to wild-type cells, and XRNA
RNAi eliminated the fast degradation component.
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Figure 4. Degradation of trypanosome EP1 mRNA is eﬀected by deadenylation-dependent and -independent pathways. (A) mRNA synthesis was
inhibited with Sinefungin and Actinomycin D in cells with inducible CAF1 RNAi, either without tetracycline or 18h after tetracycline addition. Total
RNA was prepared and the abundances of speciﬁc transcripts analysed by northern blotting. A typical blot is shown. Quantitation is on the right.
Results are arithmetic mean and standard deviation for four independent experiments. The ﬁtted lines were determined by assuming the presence of
two exponential decay components and minimising deviation from the experimental observations (see Methods section). The parameters used to ﬁt
the curves are indicated as half-life in min, and the proportion of the RNA with that half-life. (B) As for A, but using cells with RNAi targeting
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5518 Nucleic Acids Research, 2009, Vol. 37,No. 16Modelling using our previous data for the CAT-EP
mRNA (61) yielded almost identical results to those for
EP (Figure S4A).
Surprisingly, northern blots of RNA from cells con-
taining the XRNA RNAi construct had, in addition to
the expected band at 0.9kb, two additional bands: one
at 1.3kb and one at about 0.4kb. These were faint, but
detectable, in RNA from cells grown without tetracycline
(data not shown) and clearly visible after RNAi induction
(Figure 4C). Both hybridized with an EP probe containing
only the coding region; the shorter product was not
detected in the poly(A)+ fraction (data not shown) and
could be a coding region fragment. The longer product
was polyadenylated; a band of similar size hybridized to
an intergenic region probe (data not shown). This RNA is
too long to be a polyadenylated primary transcript, but
could be a previously detected minor alternatively spliced
version of EP2 or EP3 mRNA, extended at the 50-end
(86,87). Thus XRNA seems to be implicated in destruction
of abnormal, probably non-functional mRNAs from the
procyclin locus.
These results indicate that extremely rapid degradation
of EP mRNA requires XRNA, but some EP mRNA is
degraded by a pathway that depends on the presence of
CAF1.
Degradation of the CAT-PGKB and PGKB mRNAs
The endogenous PGKB mRNA, produced by pol II, is
virtually undetectable by Northern blotting. Even using
real-time PCR, the levels were only just above the detec-
tion limit, making accurate quantitation impossible (data
not shown). The only conclusion we could make was that
as for other polymerase II transcripts, the steady-state
level of PGKB mRNA did not appear to have been chan-
ged by CAF1 depletion. The mRNA level dropped below
the real-time PCR detection limit 5–15min after inhibition
of mRNA synthesis so the degradation rate could not be
measured. In order to obtain suﬃcient mRNA for analy-
sis, we therefore investigated the eﬀects of deadenylase
depletion in cell lines expressing the CAT-PGKB reporter
mRNA from an RNA polymerase I promoter. The CAT-
PGKB mRNA has a half-life of 5–7min (70,74). Depletion
of CAF1 resulted in modest stabilization (Figures 5A and
S3B). In two experiments with a PAN2 RNAi cell line, we
also saw stabilization of CAT-PGKB mRNA (see for
example upper panel of Figure 5B) but this was not seen
in two further experiments. Thus the role of PAN2 in
CAT-PGKB mRNA degradation is uncertain. From
these results we concluded that deadenylation plays a
minor role in degradation of CAT-PGKB mRNA.
TbCAF1 depletion partially inhibits 3’!5’ degradation
of CAT-EP mRNA
To examine the various degradation pathways for CAT-
EP in more detail, we depleted CAF1 in a cell line expres-
sing a CAT-GC-EP reporter, which has a C30G30 sequence
between the CAT ORF and the EP 30-UTR (61,68,74).
The C30G30 causes stalling of exoribonucleases.
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Nucleic Acids Research, 2009,Vol.37, No. 16 5519The pathways that could be responsible for the various
possible degradation intermediates [previously identiﬁed
in (61)] are depicted in Figure 6A. A CAT probe detected
the full-length CAT-GC-EP mRNA (Figure 6B, lane 1),
which was recovered in the poly(A)+ fraction (Figure 6B,
lane 3). Based on published analyses (88) we estimate that
this fraction included RNAs with tails of greater than
20nt. The CAT probe also detected a fragment containing
the 50-UTR joined to the CAT gene and terminating at
the C30G30 sequence (CAT-GC); this was in the poly(A)–
fraction as expected (Figure 6B, lanes 1 and 2). A probe
for the EP 30-UTR detected the polyadenylated CAT-GC-
EP and EP procyclin mRNAs (Figure 6B, lanes 1 and 3).
In addition, the EP probe detected two GC-EP 30-end
fragments, one of which was deadenylated (Figure 6B,
lane 2) and one of which was, on average, about 100-nt
longer and bound to oligo (dT) (Figure 6B, lane 3). The
presence of the latter fragment suggests that 50!30 exonu-
clease is able to target an mRNA with a poly(A) tail
longer than 50nt (61). Meanwhile, the deadenylated GC-
EP fragment could arise either from deadenylation of the
complete CAT-GC-EP mRNA, followed by 50!30 degra-
dation, or from deadenylation of pre-made GC-EP RNA
fragments. Thirty minutes after addition of Actinomycin
D, only shadows of deadenylated EP, CAT-GC and
GC-EP RNAs remained (Figure 6B, lanes 7 and 8); the
poly(A)+ lane (lane 9) was reproducibly empty.
We had previously shown that after XRNA depletion,
a smear of CAT-GC-EP and EP mRNAs becomes detect-
able in the steady-state poly(A)– fraction, indicating sta-
bilization of deadenylated mRNA [(61) and Figure S4B].
Exosome depletion had no eﬀect on the pattern of
intermediates at steady state, but partially stabilized
deadenylated full-length CAT-GC-EP mRNA [(74) and
Figure S4B]. Depletion of PAN2 did not result in any
obvious change in the pattern of CAT-GC-EP mRNA
degradation (data not shown). After depletion of CAF1,
the only eﬀect at steady state was in a slight decrease in the
abundance of the CAT-GC fragment relative to the
amount of CAT-GC-EP RNA (Figure 6B, lower panel,
lanes 4 and 5; see ﬁgure legend for quantitation). This
would be expected if the production of CAT-GC were
initiated by deadenylation. 30min after Actinomycin D
addition full-length mRNA was more abundant after
CAF1 depletion (Figure 6B, visible in lanes 7 and 10
hybridized with the CAT probe). More strikingly, the
poly(A)+ lane (Figure 6B, lane 12) contained some
CAT-EP mRNA, EP mRNA and the polyadenylated 30
GC-EP fragment; in contrast, for CAF1+ samples, this
lane was completely empty (Figure 6B, lane 9).
These results demonstrate the role of CAF1 in
deadenylating the CAT-GC-EP and EP mRNAs, and in
initiating 30–50 degradation.
Sequencing of uncapped mRNA reveals multiple
degradation pathways
To more characterize endogenous mRNA degradation
intermediates, we used an RNA circularization and
sequencing strategy (89). In this procedure (Figure 7A),
RNAs with a 50-phosphate and 30-OH group are diluted to
a low concentration, then incubated with T4 RNA ligase
to join the ends, creating circles. After that, the 50–30 junc-
tion is reverse transcribed, then ampliﬁed by PCR
(Figure 7A). The products are subsequently cloned and
sequenced. To sequence full-length mRNAs, the cap
must be removed since capped 50-ends cannot be ligated;
the methylated nucleotides just downstream of the cap
must also be removed because they inhibit reverse tran-
scriptase (90–94). In order to obtain ligation products
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Figure 6. Degradation of the CAT-GC-EP reporter mRNA in trypano-
somes. (A) Possible pathways of degradation. The CAT-GC-EP mRNA
has, from 50 to 30, a cap (small circle), a short 50UTR (white ﬁll), a
CAT open reading frame (black), a G30C30 sequence, then the EP1
30-UTR (white, with destabilising 26-mer in grey) and poly(A) tail
(AAAA). (1) deadenylation as the ﬁrst step in degradation (product
‘A’); (2) degradation of the deadenylated RNA from the 30-end, paus-
ing at the G30C30 sequence to produce the CAT-GC intermediate (pro-
duct ‘B’); (3) decapping of the deadenylated mRNA; product ‘C’,
indistinguishable from ‘A’ by northern blotting; (4) degradation of
product ‘C’ from the 50-end, pausing at the G30C30 sequence to give
the deadenylated 30 GC-EP RNA (product ‘E’); (5) decapping as the
ﬁrst step in degradation, to give product ‘F’, indistinguishable from the
initial RNA by northern blotting; (6) degradation of product ‘F’ from
the 50-end, pausing at G30C30 to give a polyadenylated 30 GC-EP RNA
(product ‘D’); (7) deadenylation of RNA ‘D’ to give RNA ‘E’. (B) The
eﬀect of inducible CAF1 RNAi on CAT-GC-EP mRNA degradation.
CAF1+: cells without tetracycline; CAF1 with downward arrow: cells
with tetracycline (19–21.5h). Total RNA (T) was prepared and part
of it was separated into poly(A)+ (A+) and poly(A)– (A–) fractions.
The identities of the bands are shown on the left and sizes on the right.
The upper panels were hybridized with an EP 30-UTR riboprobe.
This reproducibly cross-hybridizes with the smallest rRNA fragment.
Although this signal has been cropped from the picture, it smears a
little into the upper portions of the total and poly(A)– lanes. The lower
panels are hybridizations with a CAT probe. The ratio of the CAT-GC
fragment to the full-length mRNA fragment was measured in three
experiments: for cells without tetracycline the average ratio was 21%
(range 15–26%) and for CAF1-depleted cells 14% (range 12–16%). The
degradation fragments were detected readily only if we probed for them
ﬁrst: the upper and lower panels therefore originate from diﬀerent
experiments.
5520 Nucleic Acids Research, 2009, Vol. 37,No. 16from mRNAs with intact 50-ends and cap structures, we
therefore pre-incubated samples with RNase H and an
oligonucleotide complementary to the 50-end of the spliced
leader. When considering the results, it is important to
note that if an mRNA had been decapped in vivo, but
still retained the 50 methylated nucleotides, it would be
detected only in RNase H treated samples. Such decapped
RNAs are expected to accumulate after XRNA depletion.
Tandemly repeated precursor RNAs should be sub-
strates for RNA-ligase-independent ampliﬁcation, and
are expected for both HISH4 and TUB. We therefore
chose, as a control, the ribosomal protein L37a mRNA
(RPL37A), which is encoded by a single locus, has a pre-
dicted length of about 400nt, and has a half-life exceeding
90min in bloodstream-form trypanosomes (Figure 5B).
RNA circle results for RPL37A are shown in Figure 7B,
and sequencing results for a random selection of cloned
products are in Tables 1 and S2, and Figure S5. The
mRNA is trans spliced at a single site, but there are several
alternative polyadenylation sites. Figure 7B shows the
products of the RT–PCRs. The ﬁrst PCR showed a
ladder in all lanes, except for the negative control without
ligase (lane 5). In lanes 1 and 3, showing products from 50
RNase H-treated RNA, there was a broad band around
300nt, which was absent in the products from RNA that
had not been RNase H treated. The predicted length
for ampliﬁcation products without the poly(A) tail was
159–210bp, so the size of this band suggested average
poly(A) tail lengths of about 100nt. Cloning, however,
instead gave poly(A/T) tracts of 36–37bp. In the original
article describing the method (89), the poly(A) tails of four
rat mRNAs were measured by gel electrophoresis, without
cloning. Ampliﬁcation of three of them indicated poly(A)s
of 20–50nt; for one mRNAs there were two populations,
corresponding to 20–50nt and 120–200nt. Since mam-
malian poly(A) tails are expected to be 100–200nt long,
these results hint that the circle–PCR method may have
an intrinsic bias against longer poly(A) tails. Our results
show that the bias is exacerbated if the products are
cloned.
RPL37A products from RNA that had not been treated
with RNase H were expected to correspond to mRNAs
that had already been decapped and had begun to be
degraded from the 50-end: they formed a smear in the
agarose gel (Figure 7B). In order to reduce contamination
with irrelevant cDNAs prior to cloning, we performed a
nested PCR. Surprisingly, the 50-ends of the degradation
intermediates were not random. Instead, 25 out of 46
clones had lost the ﬁrst 27–31nt of the spliced leader.
About half of the degradation intermediates had lost the
poly(A) tail and parts of the 30-UTR as well. In contrast to
observations for mammalian histone RNAs (53), here was
no evidence for addition of U residues at the 30-ends of
the degrading mRNAs. Depletion of XRNA did not aﬀect
the patterns of degradation products. If poly(A) tails
were present they were almost always in the 30–40nt
size range. Because of the bias noted earlier, this result
gives us the lower limit of poly(A) lengths for deadenyla-
tion-dependent decapping, but does not tell us the upper
threshold. Just 2 of the 43 cloned intermediates had much
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Figure 7. RT–PCR of circularized mRNAs. (A) Illustration of the
method for intact, capped RNA (right) and a degradation intermediate
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on the ﬁgure. For detailed description see text. (B) Ethidium-bromide
stained gels of ampliﬁed products for RPL37A. A cartoon of the
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Ethidium-bromide stained gels of ampliﬁed products for EP. In the
cartoon, the striped region represents the segment encoding EP repeats.
After the ﬁrst PCR with primers 52 and 31, DNA was isolated from
the upper and lower portions of the gel, as indicated, and used for the
nested PCR using primers 51 and 32. A separate picture shows the
ladders obtained using primers 35 and 52. In each case, the area of
the gel containing most DNA was excised for puriﬁcation and cloning
of the PCR products, and clones were selected randomly for sequenc-
ing. Gels for ampliﬁcations with 30 primers 33 or 34, with 50 primer 51,
looked very similar to the lower panel for primers 51 and 32; the same
procedure was followed but only clones with the longest inserts were
sequenced.
Nucleic Acids Research, 2009,Vol.37, No. 16 5521longer poly(A) tails (93nt and 112nt), illustrating the
minor role of deadenylation-independent decay.
We next repeated the experiment for EP mRNA.
In bloodstream forms, at steady state, EP mRNAs have
a poly(A) tail of at least 50nt, added about 300-nt down-
stream of the stop codon (e.g. Figures 4 and 6B, lanes 2
and 3). Primers 52 and 31 (Figures 7C and S6) were
designed to allow detection of a broad range of degrada-
tion products, including those that had lost long segments
of the 50 and 30-ends. First, we examined RNase H-treated
mRNA, in order to see the full-length mRNA. The corre-
sponding ampliﬁed product should have been 430bp plus
poly(A). To our surprise, a band of this size was not
seen and no clones corresponding to full-length mRNA
were obtained. Instead, the RNase H-treated RNA
yielded EP products that were predominantly in the
200bp range (Figure 7C, lanes 1 and 3). Randomly
selected clones nearly all retained SL sequence, but
either lacked a poly(A) tail, or had (A)3–11 at positions
over 100-nt upstream of the usual site (Tables 1 and S3,
and Figure S7).
We next ampliﬁed EP cDNAs using RNaseH-treated
RNA from XRNA-depleted cells with primers 52 and
31. The average size of the products was shorter than
before (Figure 7B, compare lane 1 with lane 3).
Although all eight cloned products had retained the
expected portions of the spliced leader, only one of them
had a poly(A) tail (Table S3 and Figure S7). This illus-
trates stabilization of deadenylated CAT-EP mRNA after
XRNA depletion (61)
To ﬁnd out whether the procedure could amplify full-
length EP mRNA from bloodstream forms at all, we
repeated ampliﬁcations with primers 33 and 34 and
selected only the longest inserts for sequencing (Table S4
and Figure S8). The product distributions on agarose gels
were similar to those obtained with the ﬁrst primer sets
(data not shown). Even with primer 34, no clones
had poly(A) in the expected position, although one was
polyadenylated a few nucleotides further downstream
(Figure S8). This result is strange, since it is inconsistent
with the northern blot results. It will not be discussed
further here, because a considerable number of further
experiments is required to determine the origin of these
products. In procyclic forms, the EP mRNA is very stable
and polyadenylated. In preliminary experiments with
RNaseH-treated mRNA from this form, using primers
33 and 34, 6 out of 12 clones were polyadenylated in the
expected position at +297, with an average poly(A) length
of 29nt (maximum 58nt). This shows that the procedure
can indeed amplify the full-length polyadenylated RNA,
but probably biases towards shorter products and trun-
cates the tails.
Returning to the bloodstream-form trypanosomes, we
next analysed circularized EP mRNAs without prior
RNAase treatment. Using RNA from cells with normal
XRNA levels, approximately half of the ampliﬁed pro-
ducts using 30 primer 32 had an oligo(A) tail, well
upstream of the expected position; the intermediates with-
out poly(A) had lost variable portions of the 30-UTR.
It was obvious on the stained agarose gel that products
from cells with XRNA RNAi (Figure 7C, lane 2) were
smaller than those obtained from cells with a normal
amount of XRNA (Figure 7C, lane 4). The clones from
the XRNA-depleted cells mostly lacked poly(A) and had
been digested signiﬁcantly further at the 50-end than those
from the normal cells: 56% had lost part of the coding
region, and only 1/18 had retained part of the spliced
leader, while in XRNA positive cells, 14% had lost
coding sequence and 64% retained part of the spliced
leader. Surprisingly although the coding region primers
were designed to hybridize equally to EP1, EP2 and
EP3 sequences, all clones originated from EP1. Two
clones (no RNase H, normal XRNA) originated from
the primary transcript, enabling precise mapping of the
transcription start site at position  115 relative to the
start codon.
Table 1. Summary of results for circularized RNAs
Gene RNaseH XRNA # Nt 50 nt 30 pA (%) (A)n
RPL37A full 55 108–136
RPL37A circles + + 5 38 4 108, 127, 136 100 36 4
  +2 3 2 7  87 8  42 43 44 (5–93)
+   53 9  4 108,136 100 36 5
   20 20 15 97 37 50 34 (5–112)
EP full 70 312
EP circles + + 8 49 25 37 22 62 7 (3–11)
  +2 3 3 8  33
a,  29 35 59 12 (3–28)
+   85 7  12 8  22 12 10
   16  11 28  76 98 19 5 (4,5)
Results are shown for products of RPL37A ampliﬁed with the ‘b’ primers (Figure 7B) and for EP mRNAs ampliﬁed with 50 primers 51 or 52, and
30-primer 32 (Figure 7C). ‘RNase H’—removal of 50-end of SL by RNase H digestion; ‘XRNA’—presence of normal XRNA (+) or depleted XRNA
( ). # denotes number of clones sequenced; in each case, clones with various insert lengths were selected. Results for 50 and 30 ends (nt 50,n t3 0) are
the numbers of nucleotides beyond the ATG start codon or the stop codon, respectively, expressed as arithmetic mean SD, including clones with
and without poly(A). The lengths for full-lengths RNA are given for reference (‘full’) and are shown in italics. ‘pA’ shows the percentage of clones
that had a poly(A) tail. The ‘(A)n’ lane indicates the arithmetic mean lengths of poly(A) tails, where present, with either the standard deviation or
the range.
aNot including the primary transcripts.
 Signiﬁcantly diﬀerent, P<0.001 (t-test).
5522 Nucleic Acids Research, 2009, Vol. 37,No. 16Finally, results in Figure 4C had suggested that XRNA
depletion stabilized an intermediate of about 400nt.
Since this fragment had not been detected from CAT-EP
mRNAs after XRNA depletion (61), we suspected that it
might depend on the EP coding region. We looked for
such RNAs using primers 52 and 35; the latter hybridizes
within the repetitive region encoding the EP repeats. The
result was a clean ladder of products which was unaﬀected
by either RNase H decapping or XRNA depletion
(Figure 5C). All clones obtained, (with or without
XRNA depletion) started at position +51 downstream
of the ATG, and ended at position 10 in the 30-UTR.
This was paradoxical since no clones obtained with
other primers had these boundaries.
Two novel ﬁndings emerged from this approach.
First, we saw hitherto unsuspected heterogeneity in
polyadenylation of EP mRNAs in bloodstream forms.
Second, XRNA depletion caused accumulation of EP
mRNA degradation intermediates that lacked not only
the poly(A) tail, but also portions of the 50-end. We
were disappointed that we could not establish an upper
poly(A) length threshold for deadenylation-dependent
decapping; nevertheless, it was interesting that cloned
EP mRNAs had much shorter poly(A)s than the
RPL37A clones.
RNAi targeting a MEX67 homologue does not
accelerate EP mRNA decay
XRNA is present in both the nucleus and the cytoplasm,
so could theoretically attack EP and PGKB mRNA imme-
diately after synthesis, prior to nuclear export. To address
this possibility, we searched for homologues of the export
factor MEX67 (human TAP). The protein predicted from
one, Tb927.5.1270, is only 216 amino acids long, and
RNAi had no eﬀect on growth (data not shown). The
protein encoded by Tb11.22.0004 is, in contrast,
closer to the expected length, has two NTF2 homology
domains (superfamily SSF54427), and is 30% identical
(49% similar) to mouse TAP/MEX67 over the ﬁrst 158
amino acids. RNAi targeting Tb11.22.0004 inhibited
growth (Figure 8A). We used in situ hybridization to
examine the distribution of poly(A) after RNAi targeting
Tb11.22.0004. In normal cells, or RNAi cells without
tetracycline addition, poly(A) was always distributed uni-
formly throughout the cytoplasm and nucleus (Figure 8B).
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Figure 8. (A) RNAi targeting T. brucei MEX67 inhibits growth. A cumulative growth curve is shown. (B and C) RNAi targeting T. brucei MEX67
results in accumulation of poly(A)+ RNA in the nucleus. Cells without an RNAi construct (B) or cells with inducible RNAi (C) were incubated with
or without tetracycline for 48h. poly(A) was detected in the cells by in situ hybridization (p(A)). The DNA stain (DAPI) is on the right; some
outlines of the parasites are added (dotted lines) to facilitate interpretation. (D) Eﬀect of MEX67 RNAi on mRNA levels. RNA was prepared at the
indicated times after tetracycline addition and EP, PGK, and 7SL mRNAs were detected. (E) Quantitation of two experiments as in (D). The amount
of PGKC mRNA in cells without an RNAi construct (WT) was set to 1.0; for EP and PGKB, the amount of mRNA at 48h was set to 1.0. A third
experiment gave similar results but the signals were too faint for quantitation.
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ing from normal poly(A) staining to strong retention of
poly(A) in the nucleus (Figure 8C). These results, seen
with several independent RNAi lines, suggest that the
Tb11.22.0004 locus indeed encodes a MEX67-like protein
that is required for mRNA export, so we have named the
gene TbMEX67.
If the XRNA pathway were in the nucleus, one would
expect a decrease in EP and PGKB mRNAs after MEX67
RNAi. Instead, MEX67 RNAi reproducibly caused an
increase in both mRNAs (Figure 8D and E). At the
same time, PGKC mRNA decreased. In normal blood-
stream forms, the PGKC:PGKB ratio was greater than
10:1; after MEX67 RNAi, the ratio changed to about
4:1. Results of a preliminary cell fractionation experiment
suggested that even after 48h tetracycline treatment, most
of the EP mRNA was in the cytoplasm (data not shown).
This is consistent with the in situ hybridization results
suggesting that mRNA export from the nucleus had
slowed down, but not stopped. These results lent no sup-
port to the notion that degradation of either EP or PGKB
mRNA occurs in the nucleus.
DISCUSSION
Roles of PAN2 and PAN3 in trypanosomes
In yeast and animals, the roles of the PAN2/PAN3 com-
plex may be mainly in quality control—trimming poly(A)
tails in the nucleus and cytoplasm. The complex is not
essential in yeast, and appears to have been lost many
times in eukaryotic evolution. In addition, some organ-
isms have truncated or mutant versions of PAN2 which
have lost active site residues. PAN3 was present in most
organisms that had PAN2, but absent in all that lacked it.
Even in Plasmodium, which shows translational regulation
(95) and has few potential regulatory transcription factors
(96), we could ﬁnd no PAN2/3.
Homologues of PAN2 and PAN3 are present in the
trypanosome genome. Results from RNAi suggested
that PAN2 is required for optimal trypanosome growth.
We found no indication that PAN3 is required for PAN2
activity, and evidence for a PAN2–PAN3 interaction was
weak. The eﬀects of RNAi targeting PAN2 were diﬃcult
to analyse since the RNAi eﬀect was rapidly lost during
culture. Nevertheless, it was clear that even when PAN2
depletion was suﬃcient to stop trypanosome growth, the
degradation kinetics of several mRNAs were unchanged.
In contrast, there was clear stabilization of the regulated
EP mRNA and mild inhibition of ACT and CAT-PGKB
mRNA decay. These results suggest that PAN2 may have
a specialized role in degrading some, but not all mRNAs.
Decapping in trypanosomes
Decapping has been seen in trypanosome extracts (60),
and was also measured indirectly in Leishmania (97).
RNAi targeting the only reasonable candidate for a try-
panosome DCP2-like decapping enzyme, Tb10.70.2530,
did not aﬀect cell growth (for details see Supplementary
Data). We therefore wondered whether trypanosome
mRNAs were decapped by some other mechanism.
Since all mRNAs have a 50 SL, sequence-speciﬁc endonu-
clease digestion within the SL could substitute for decap-
ping. To analyse this we used RNA ligation and PCR to
clone mRNA degradation intermediates. When we exam-
ined decay intermediates of the mRNA encoding ribo-
somal protein L37A, there was a favoured 50-end, at
positions 28–31 of the SL. However, the frequency of
this was not increased after XRNA depletion, as would
be expected for an endonuclease product. Moreover, some
L37A RNAs had more SL sequence, and a similar pattern
was not seen for EP mRNA. The result for L37A could be
an artefact of the method. If it is not, there might be an
SL-speciﬁc endonuclease, aﬀecting some, but not all,
mRNAs. Alternatively, XRNA (or another unidentiﬁed
50–30 exoribonuclease) may pause in vivo at position
28–31 because of secondary structure or the presence of
bound protein.
CAF1 depletion increased the steady-state abundance
of EP mRNA
Depletion of CAF1 almost completely stopped degrada-
tion of HISH4, TUB, ACT and PGKC mRNAs but the
steady-state abundances were unaﬀected (14). We pre-
viously suggested that when mRNA degradation is
stopped, a feedback mechanism might inhibit RNA poly-
merase II transcription. In contrast, depletion of CAF1
selectively increased the abundances of EP mRNA,
which is made by RNA polymerase I. It is therefore
possible that if a feedback mechanism exists, RNA poly-
merase I is less susceptible to it than RNA polymerase II.
Also, it has recently been shown in S. cerevisiae that the
Rpb4 and Rpb7 subunits of RNA polymerase II play
roles in mRNA degradation (98,99). It is conceivable
that these subunits also inﬂuence mRNA decay in trypa-
nosomes (100).
Deadenylation and decapping of the L37A mRNA
In mammalian cells, decapping occurs on mRNAs that
have reduced poly(A) tail lengths; the threshold may cor-
respond to a minimum number of 25-nt-binding sites for
PABP (101,102). In studies of budding yeast, the dead-
enylation limit is indeed 10–20 residues (103,104) though
not many transcripts have been analysed in detail. A study
of four mammalian liver mRNAs, using circularization,
found that for one, decapped mRNAs had poly(A) tails
of 20–60nt, but the three others had shorter tails; there
was no obvious relationship between the minimum tail
length and the mRNA half-life (89). The stable beta-
globin mRNA exhibits synchronous deadenylation until
the poly(A) tail has a length of about 110nt; after that,
an asynchronous reduction to A(20) is observed before the
mRNA is degraded (26). In contrast, completely deadeny-
lated cmyc mRNA has been detected (105).
Our previous experiments had suggested that the
poly(A) tails on histone H4 mRNA are reduced to
about 50nt before the mRNA body is degraded (14,61).
Our attempts to analyse overall poly(A) lengths of the
L37A mRNA by sequencing RT–PCR ampliﬁed, circular-
ized mRNAs were thwarted by methodological bias
towards shorter products. Nevertheless, the majority of
5524 Nucleic Acids Research, 2009, Vol. 37,No. 16products were consistent with deadenylation-dependent
decay. XRNA depletion had no eﬀect on the overall pat-
tern, and we can suggest a lower limit of A(30–40) for the
threshold for decapping. The presence of short tails
in nearly half of the decapped intermediates implies a
temporal and mechanistic discontinuity in the decay pro-
cess: after deadenylation reaches the threshold, the
mRNA is decapped, but there is then a pause while the
short-tailed, decapped mRNA is ‘handed over’ to the 50–30
exoribonuclease and/or the exosome.
Polyadenylation of EP mRNA
All evidence from northern blotting indicates that most
EP mRNAs in bloodstream-form trypanosomes are poly-
adenylated at approximately the same position as in pro-
cyclic forms, about 300nt downstream of the stop codon,
and that the poly(A) tail is at least 50-nt long (see e.g.
Figure 4). We were therefore surprised that after circle-
PCR, almost all of the cloned polyadenylated EP RNAs
had shorter 30-UTRs. If such mRNAs were as abundant as
the cloning results imply, the northern would have a smear
and no full-length band at all. These mRNAs are never-
theless probably present, albeit at much lower abundance
than the cloning results suggest. They could arise by use of
alternative processing signals: this has been seen for EP
before, but only in reporters with deletions of the wild-
type sequence (87,106), Alternatively, oligo(A) tails might
have been added to degradation intermediates in the cyto-
plasm. The exosome from some Archaea has the ability to
add nucleotides to RNA; adenosine is added preferentially
because ATP is most abundant in the cytoplasm (107).
The trypanosome exosome lacks RNase PH activity
(108), so is unlikely to be able to catalyse the polyadenyla-
tion reaction, but some other cytoplasmic protein might
conceivably have this function.
Pathways of EP mRNA degradation
We previously suggested that in bloodstream-form trypa-
nosomes, CAT-EP, EP and PGKB mRNAs are destroyed
by two pathways, one dependent on XRNA and the other
on deadenylation. The results presented here suggest a
more complicated picture. The presence of very active,
and at least partially deadenylation- independent, 50–30
pathway for EP mRNA degradation is supported by the
presence of polyadenylated CAT-GC-EP degradation
intermediates, and by the inhibition of degradation by
depletion of XRNA. However, we also found deadeny-
lated CAT-GC-EP intermediates, and 30–50 exonuclease
products from both CAT-GC-EP and EP. The EP
mRNA degradation kinetics included a fast, XRNA-
dependent component and a slower one dependent
on CAF1. Even the rapid degradation pathway, had a
30-exonucleolytic component: it was made slower by
CAF1 depletion, and was delayed by RNAi targeting
the exosome (74).
Yeast XRN1 is processive on a poly(A) substrate (109).
If XRNA were processive on mRNA in vivo, a reduction
in the XRNA level should cause accumulation of full-
length, but decapped EP mRNA, but should not change
the overall distribution of mRNAs in which are ‘caught in
the act’ of 50 degradation at the time of RNA isolation.
If XRNA were distributive in vivo, RNAi should cause
accumulation of many diﬀerent 50 degradation products;
the same picture would be obtained if, after XRNA deple-
tion, decapped mRNAs were degraded by a diﬀerent, dis-
tributive, 50–30 exoribonuclease. Inhibition by secondary
structures, bound proteins and ribosomes could also
aﬀect the pattern. We found that the cloned intermediates
from XRNA-depleted cells were signiﬁcantly shorter at
the 50-end than those from normal cells. There are multiple
possible explanations, and we present just one, highly
speculative, scenario here. Suppose that in normal cells,
XRNA is responsible for most 50–30 degradation: its activ-
ity is transiently delayed by the exon junction complex or
other proteins bound to the spliced leader; but once over
this barrier, digestion is processive. This would explain the
predominance of intermediates that retain parts of the
spliced leader in normal cells. In the absence of XRNA,
decapped mRNA accumulates, and is either attacked from
the 30-end, or degraded from the 50-end by other, distrib-
utive exoribonucleases, or by endonucleases.
When CAF1 was depleted, half of the EP mRNA was
degraded within 15min, but the rest appeared to be very
stable, and so apparently not susceptible to degradation
by other enzymes. This suggests mechanistic separation
of the CAF1-dependent and -independent pathways.
Temporal separation, with deadenylation-independent
degradation only within the ﬁrst 15min after synthesis,
would be easily understood if the XRNA pathway were
located in the nucleus; but this is unlikely, since EP
mRNA accumulated after depletion of MEX67. CAF1
RNAi might also result in abnormal sequestering of
mRNAs in stress granules (62) or other structures (110).
We looked for this, but 24h after induction of RNAi
against either CAF1 or NOT1 there was little, if any
eﬀect on the distribution of the helicase DHH1 (data
not shown), which is a stress granule marker (62).
We suggest that the choice of mRNA degradation path-
way is dictated by binding of diﬀerent combinations of
regulatory RNA-binding proteins. The RPL37A, HISH4
and other relatively stable mRNAs are bound by combi-
nations of RNA-binding proteins that actively prevent
degradation (111); deadenylation is slow, but at a thresh-
old (minimally, A30–40) there is a pause before subsequent
attack at the 50 and 30 ends. Protein combinations speciﬁc
for EP, PGKB and related unstable mRNAs, in contrast,
can actively recruit either XRNA and the elusive decap-
ping enzyme, or deadenylases; this causes either very rapid
degradation initiated from the 50-end, or a rapid entry
to the deadenylation-dependent pathway. If XRNA is
not available, the mRNA defaults to the deadenylation-
dependent pathway. Possibly, the RNA-binding proteins
route the highly unstable mRNAs directly to P-bodies.
This scenario is entirely consistent with results from
other eukaryotes. For example, the alpha1 tubulin
mRNA of Chlamydomonas reinhardtii is normally
degraded via deadenylation followed by decapping and
50–30 digestion. After deﬂagellation, synthesis of the
mRNAs is induced, but their half-lives decrease to
10–15min, and 50 degradation occurs without deadenyla-
tion (112). Mammalian mRNAs with diﬀerent AU-rich
Nucleic Acids Research, 2009,Vol.37, No. 16 5525elements also show diﬀerent deadenylation kinetics (113).
The next challenge, for trypanosomes, consists in identify-
ing the RNA-binding proteins that guide these choices.
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